Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Supportive Care Medicine market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Supportive Care Medicinemarket, defines the market attractiveness level of Cancer Supportive Care Medicine market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Supportive Care Medicine industry, describes the types of Cancer Supportive Care Medicine market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Supportive Care Medicine market and the development prospects and opportunities of Cancer Supportive Care Medicine industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Supportive Care Medicine market in Chapter 13.
By Player:
Heron Therapeutics
Novartis
Teva Pharmaceutical Industries
Johnson &Johnson
Amgen
Kyowa Hakko Kirin
GlaxoSmithKline
Helsinn Healthcare
TESARO
Merck
By Type:
Antiemetic Drugs
Erythropoietin-Stimulating Agents
Granulocyte-Stimulating Agents
Analgesics
Others
By End-User:
Chemotherapy-Induced Anemia
CINV
Bone Metastasis
Cancer Pain
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Supportive Care Medicine Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Supportive Care Medicine Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Supportive Care Medicine Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Supportive Care Medicine Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Supportive Care Medicine Market Analysis and Outlook to 2022
-
7.1 Global Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.2 United States Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.3 Europe Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.4 China Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.5 Japan Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.6 India Cancer Supportive Care Medicine Consumption (2017-2022)
-
7.7 South Korea Cancer Supportive Care Medicine Consumption (2017-2022)
8 Region and Country-wise Cancer Supportive Care Medicine Market Analysis and Outlook to 2028
-
8.1 Global Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.2 United States Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.4 China Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.6 India Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Supportive Care Medicine Consumption Forecast (2022-2028)
9 Global Cancer Supportive Care Medicine Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Supportive Care Medicine Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Erythropoietin-Stimulating Agents Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Granulocyte-Stimulating Agents Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Analgesics Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Supportive Care Medicine Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Chemotherapy-Induced Anemia Consumption and Growth Rate (2017-2022)
-
9.2.2 Global CINV Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cancer Pain Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Cancer Supportive Care Medicine Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Supportive Care Medicine Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Erythropoietin-Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Granulocyte-Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Supportive Care Medicine Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Chemotherapy-Induced Anemia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global CINV Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cancer Pain Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Supportive Care Medicine Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Supportive Care Medicine Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Supportive Care Medicine Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Supportive Care Medicine Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Supportive Care Medicine Market Competitive Analysis
-
14.1 Heron Therapeutics
-
14.1.1 Heron Therapeutics Company Details
-
14.1.2 Heron Therapeutics Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Heron Therapeutics Cancer Supportive Care Medicine Product and Service
-
14.2 Novartis
-
14.2.1 Novartis Company Details
-
14.2.2 Novartis Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Novartis Cancer Supportive Care Medicine Product and Service
-
14.3 Teva Pharmaceutical Industries
-
14.3.1 Teva Pharmaceutical Industries Company Details
-
14.3.2 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Teva Pharmaceutical Industries Cancer Supportive Care Medicine Product and Service
-
14.4 Johnson &Johnson
-
14.4.1 Johnson &Johnson Company Details
-
14.4.2 Johnson &Johnson Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson &Johnson Cancer Supportive Care Medicine Product and Service
-
14.5 Amgen
-
14.5.1 Amgen Company Details
-
14.5.2 Amgen Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Amgen Cancer Supportive Care Medicine Product and Service
-
14.6 Kyowa Hakko Kirin
-
14.6.1 Kyowa Hakko Kirin Company Details
-
14.6.2 Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Kyowa Hakko Kirin Cancer Supportive Care Medicine Product and Service
-
14.7 GlaxoSmithKline
-
14.7.1 GlaxoSmithKline Company Details
-
14.7.2 GlaxoSmithKline Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 GlaxoSmithKline Cancer Supportive Care Medicine Product and Service
-
14.8 Helsinn Healthcare
-
14.8.1 Helsinn Healthcare Company Details
-
14.8.2 Helsinn Healthcare Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Helsinn Healthcare Cancer Supportive Care Medicine Product and Service
-
14.9 TESARO
-
14.9.1 TESARO Company Details
-
14.9.2 TESARO Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 TESARO Cancer Supportive Care Medicine Product and Service
-
14.10 Merck
-
14.10.1 Merck Company Details
-
14.10.2 Merck Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Merck Cancer Supportive Care Medicine Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Supportive Care Medicine
-
Figure Cancer Supportive Care Medicine Picture
-
Table Global Cancer Supportive Care Medicine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Supportive Care Medicine Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Supportive Care Medicine Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Supportive Care Medicine Consumption by Country (2017-2022)
-
Figure United States Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Supportive Care Medicine Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Supportive Care Medicine Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Supportive Care Medicine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Antiemetic Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Erythropoietin-Stimulating Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Granulocyte-Stimulating Agents Consumption and Growth Rate (2017-2022)
-
Figure Global Analgesics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy-Induced Anemia Consumption and Growth Rate (2017-2022)
-
Figure Global CINV Consumption and Growth Rate (2017-2022)
-
Figure Global Bone Metastasis Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Pain Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Antiemetic Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Erythropoietin-Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Granulocyte-Stimulating Agents Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Analgesics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy-Induced Anemia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CINV Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Bone Metastasis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Pain Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Supportive Care Medicine Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Supportive Care Medicine Export by Region (Top 5 Countries) (2017-2028)
-
Table Heron Therapeutics (Foundation Year, Company Profile and etc.)
-
Table Heron Therapeutics Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Heron Therapeutics Cancer Supportive Care Medicine Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Supportive Care Medicine Product and Service
-
Table Teva Pharmaceutical Industries (Foundation Year, Company Profile and etc.)
-
Table Teva Pharmaceutical Industries Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Teva Pharmaceutical Industries Cancer Supportive Care Medicine Product and Service
-
Table Johnson &Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson &Johnson Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson &Johnson Cancer Supportive Care Medicine Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Cancer Supportive Care Medicine Product and Service
-
Table Kyowa Hakko Kirin (Foundation Year, Company Profile and etc.)
-
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Kyowa Hakko Kirin Cancer Supportive Care Medicine Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Cancer Supportive Care Medicine Product and Service
-
Table Helsinn Healthcare (Foundation Year, Company Profile and etc.)
-
Table Helsinn Healthcare Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Helsinn Healthcare Cancer Supportive Care Medicine Product and Service
-
Table TESARO (Foundation Year, Company Profile and etc.)
-
Table TESARO Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table TESARO Cancer Supportive Care Medicine Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Supportive Care Medicine Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Supportive Care Medicine Product and Service
-
